Upgrade to SI Premium - Free Trial

Celestica (CLS) PT Lowered to $406 at Barclays

August 7, 2026 4:53 AM
Barclays analyst George Wang lowered the price target on Celestica (NYSE: CLS) to $406.00 (from $430.00) while maintaining a Overweight rating.

Categories

Analyst PT Change